Dr. Edward Lynch (Dental) this week was installed as president of the Pharmacology, Therapeutics and Toxicology Research Group at the annual meeting of the International Association for Dental Research (IADR) and American Association for Dental Research (AADR) in London. He was elected by his peers as Research Group president for the third time. At the meeting he served as group program chair, refereeing submissions as well as structuring scientific sessions. He also was chairperson of a scientific session and chairperson of the annual business meeting and was elected and attended the annual International Association for Dental Research Council meeting. Additionally, he made a presentation on one of his current clinical trials, "Ozone Treatment of Symptomatic, Deep, Almost Cariously Exposed Lesions." He also was elected to attend the 2019 Council of the International Association for Dental Research, which he will also attend as the president of the Pharmacology, Therapeutics and Toxicology Research Group of IADR and AADR.